| Tag |
First Indicator |
Second Indicator |
Subfields |
| LEADER |
00000cam a2200000 i 4500 |
| 001 |
in00004039321 |
| 005 |
20191023090551.0 |
| 006 |
m o d f |
| 007 |
cr bn||||a|||| |
| 008 |
180326s2018 dcua ob f000 0 eng c |
| 035 |
|
|
|a (OCoLC)on1029561452
|
| 042 |
|
|
|a pcc
|
| 043 |
|
|
|a n-us---
|
| 040 |
|
|
|a GPO
|b eng
|e rda
|e pn
|c GPO
|d GPO
|d MERUC
|d OCLCF
|d UOK
|d GPO
|d INT
|d GPO
|d OCLCQ
|d OCLCO
|d OCLCA
|d GPO
|d TEU
|d OCLCO
|d IAS
|d OCLCO
|d TXR
|d OCLCO
|d GPO
|d MvI
|
| 049 |
|
|
|a WWW
|
| 050 |
|
4 |
|a KF27
|b .E5546 2017d
|
| 074 |
|
|
|a 1019-C-01 (online)
|
| 086 |
0 |
|
|a Y 4.C 73/8:115-46
|
| 088 |
|
|
|a Serial no. 115-46 (United States. Congress. House. Committee on Energy and Commerce)
|
| 110 |
1 |
|
|a United States.
|b Congress.
|b House.
|b Committee on Energy and Commerce.
|b Subcommittee on Oversight and Investigations,
|e author.
|
| 245 |
1 |
0 |
|a Examining HRSA's oversight of the 340B Drug Pricing Program :
|b hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session, July 18, 2017.
|
| 246 |
3 |
|
|a Examining Health Resources and Services Administration's oversight of the 340B Drug Pricing Program
|
| 264 |
|
1 |
|a Washington :
|b U.S. Government Publishing Office,
|c 2018.
|
| 300 |
|
|
|a 1 online resource (iii, 104 pages) :
|b illustrations
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 504 |
|
|
|a Includes bibliographical references.
|
| 500 |
|
|
|a "Serial No. 115-46."
|
| 588 |
0 |
|
|a Online resource, PDF version; title from title page (Govinfo web site, viewed Mar. 26, 2018).
|
| 610 |
2 |
0 |
|a 340B Drug Pricing Program (U.S.)
|
| 610 |
1 |
0 |
|a United States.
|b Health Resources and Services Administration.
|
| 650 |
|
0 |
|a Prescription pricing
|x Government policy
|z United States.
|
| 650 |
|
0 |
|a Poor
|x Pharmaceutical assistance
|z United States.
|
| 650 |
|
0 |
|a Older people
|x Pharmaceutical assistance
|z United States.
|
| 655 |
|
7 |
|a Legislative hearings.
|2 lcgft
|
| 776 |
0 |
8 |
|i Microfiche version:
|a United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations.
|t Examining HRSA's oversight of the 340B Drug Pricing Program
|w (OCoLC)1048614454
|
| 776 |
0 |
8 |
|i Print version:
|a United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations.
|t Examining HRSA's oversight of the 340B Drug Pricing Program
|w (OCoLC)1028992481
|
| 856 |
4 |
0 |
|u https://purl.fdlp.gov/GPO/gpo90256
|t 0
|
| 999 |
f |
f |
|s 960130d4-9141-3571-9c7c-91b2d666a117
|i c330049e-7a9a-376f-afd4-57b9abf62935
|t 0
|
| 952 |
f |
f |
|a Texas A&M University
|b College Station
|c Electronic Resources
|d Available Online
|t 0
|e Y 4.C 73/8:115-46
|h Superintendent of Documents classification
|
| 998 |
f |
f |
|a Y 4.C 73/8:115-46
|t 0
|l Available Online
|